Stemtech Corporation

STEK ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-292.4K $-1.3M $-1.5M $-809.4K $-293.1K $-1.5M $-396.6K $-1.2M
Depreciation & Amortization $41.9K $41.9K $41.9K $41.9K $41.9K $41.9K $185.0K $0
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $109.5K $108.3K $110.7K $110.7K $109.5K $108.3K $209.1K $0
Net Cash from Operating Activities $-54.8K $-425.9K $127.0K $25.0K $75.0K $-710.5K $-270.9K $-1.2M
Investing Activities
Capital Expenditures $0 $0 $0 $0 $0 $0 $0 $0
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $0 $0 $0 $0 $0 $0 $0 $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $200.2K $-22.8K $69.4K $-161.5K $473.4K $78.8K $1.0M $0
Net Change in Cash $-9.4K $17.9K $-17.2K $-17.0K $-33.4K $50.5K $1.2M $-1.2M
Free Cash Flow $-54.8K $-425.9K $127.0K $25.0K $75.0K $-710.5K $-270.9K $-1.2M
← Newer Page 1 of 7 Older →